zotatifin
effector therapeutics
['zotatifin', 'eft226', 'effector therapeutics']
effector therapeutics reports positive interim results in zotatifin (eft226) phase 1/2 clinical trial at asco 2022 showing safety and tolerability, and initial signals of clinical activity bio tech winners 
Brother's Technology
Best Website for Technology and Gadget